Code: MTA3439 | Publication Date: Mar 2025 |
The growth of the India's Active Pharmaceutical Ingredient Market can be associated with several factors such as cost competitiveness, skilled workforce, support for state policy and improving the regulatory environment. In addition, high opportunities in the research and development field have also contributed to the market growth. The country's low production costs and vastly qualified workers make it an attractive place for global pharmaceutical companies that subcontract API production.
While in India, there are many players in the API market, but several major players have contributed significantly to their growth. These companies have been Establishment Year as industry leaders and played a decisive role in promoting innovation and carrying out API production. They also occupy an important part in the national and international API markets, which makes them key players in the general growth of the Indian pharmaceutical industry.
Attributed to the growing demand for APIs, India offers profitable investment capabilities to internal and international companies. The government is focused on promoting the growth of the pharmaceutical industry through initiatives like Pharma Vision 2020. Furthermore, there is great potential for India Active Pharmaceutical Ingredient Market Growth as demand for global generics increases. According to 6Wresearch, India Active Pharmaceutical Ingredient Market size is estimated to rise at a significant CAGR of 12% during 2025-2031.
Company Name | Sun Pharmaceutical Industries Ltd. |
Establishment Year | 1983 |
Headquarter | Mumbai |
Official Website | Click Here |
Sun Pharmaceutical Industries Ltd. is the largest pharmaceutical company in India and also one of the leading global players in the industry. The company specializes in manufacturing APIs, generic drugs, and other pharmaceutical products. They have a wide range of products that cater to various therapeutic areas such as cardiology, psychiatry, neurology, gastroenterology, etc.
Company Name | Aurobindo Pharma Ltd. |
Establishment Year | 1986 |
Headquarter | Hyderabad, India |
Official Website | Click Here |
Aurobindo Pharma Ltd. is a multinational pharmaceutical company headquartered in Hyderabad, India. The company has a diverse portfolio of APIs and finished dosage formulations (FDF) catering to various therapeutic areas. Aurobindo Pharma has a strong presence in both domestic and international markets, with exports to over 150 countries.
Company Name | Dr. Reddy's Laboratories Ltd. |
Establishment Year | 1984 |
Headquarter | Hyderabad |
Official Website | Click Here |
Dr. Reddy's Laboratories Ltd. is a leading pharmaceutical company based in Hyderabad, India. The company manufactures and markets a wide range of APIs and FDFs globally, with products spanning across multiple therapeutic categories such as cardiovascular, neurology, gastroenterology, etc. They also have a significant presence in the biosimilars market.
Company Name | Cipla Ltd. |
Establishment Year | 1935 |
Headquarter | Mumbai |
Official Website | Click Here |
Cipla Ltd. is a global pharmaceutical company with headquarters in Mumbai, India. The company has a strong presence in over 170 countries and offers a wide range of APIs and FDFs across various therapeutic areas such as respiratory, oncology, cardiovascular, etc. In addition to APIs, Cipla also has a significant focus on research & development for innovative drug formulations.
Company Name | Lupin Ltd. |
Establishment Year | 1968 |
Headquarter | Mumbai |
Official Website | Click Here |
Lupin Ltd. is a pharmaceutical company headquartered in Mumbai, India, with a global presence in over 100 countries. The company has a diverse portfolio of APIs and FDFs catering to various therapeutic areas such as cardiovascular, respiratory, diabetes, etc. Lupin also specializes in the development of complex generics and biosimilars.
Company Name | Cadila Healthcare Ltd. |
Establishment Year | 1952 |
Headquarter | Ahmedabad |
Official Website | Click Here |
Cadila Healthcare Ltd., also known as Zydus Cadila, is an Indian pharmaceutical company headquartered in Ahmedabad, India. The company has a robust portfolio of APIs and FDFs that cater to a wide range of therapeutic areas such as gastroenterology, respiratory, pain management, etc. They also have a strong focus on research & development for innovative drug formulations.
Company Name | Divi's Laboratories Ltd. |
Establishment Year | 1990 |
Headquarter | Hyderabad |
Official Website | Click Here |
Divi's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, India. The company primarily focuses on the manufacture and sale of APIs and intermediates globally. Divi's Laboratories has a strong presence in the research and development of new drug formulations, with a focus on developing sustainable and eco-friendly processes.
Company Name | Biocon Ltd. |
Establishment Year | 1978 |
Headquarter | Bengaluru |
Official Website | Click Here |
Biocon Ltd. is an Indian biopharmaceutical company headquartered in Bengaluru, India. The company specializes in manufacturing APIs, biosimilars, and innovative drug formulations for various therapeutic areas such as diabetes, oncology, nephrology, etc. They are also one of the leading players in the global insulin market.
Company Name | Piramal Enterprises Ltd. |
Establishment Year | 1984 |
Headquarter | Mumbai |
Official Website | Click Here |
Piramal Enterprises Ltd. is a global pharmaceutical company headquartered in Mumbai, India. The company has a diverse portfolio of APIs and FDFs catering to various therapeutic areas such as critical care, pain management, etc. Piramal also has a strong focus on research & development for developing innovative drug formulations.
Company Name | Jubilant Life Sciences Ltd. |
Establishment Year | 1978 |
Headquarter | Noida |
Official Website | Click Here |
Jubilant Life Sciences Ltd. is an Indian multinational pharmaceutical company based in Noida, India. The company has a strong presence in the global market for both APIs and FDFs, with products spanning across multiple therapeutic categories such as cardiovascular, neurology, etc. Jubilant also has a significant focus on research & development for new drug formulations.